Clover Health Debuts New Medicare Advantage Plans for 2022

NEXT STORY
First Watch Restaurant Group, Inc. Announces Initial Public Offering
PREV STORY
Ikena Oncology to Present a Trial-in-Progress Update, Translational Data, and Indication Selection Methodology for Novel AHR Inhibition Program at the 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Health Needs Spike for Survivors of Indonesia’s Earthquake and Tsunami

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Top-Line Results from Week 84 of Its Phase 2 PaTH Forward Trial Demonstrating that TransCon™ PTH Provided Durable Benefit and Was Well-Tolerated in Adults with Hypoparathyroidism

author_avatar
NASDAQ Market News

Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Lead candidate pepinemab (VX15) being evaluated in three ongoing clinical trials in cancer and ...

author_avatar
NASDAQ Market News